Clinical trial

Expression of Mif Alleles in Individuals With Leishmaniasis

NCT00401349 · Yale University, Other · Completed

Key facts

NCT number NCT00401349
Title Expression of Mif Alleles in Individuals With Leishmaniasis
Official title Immune and Inflammatory Responses in L. (Viannia) Infection Aim 2: Expression of Mif Alleles in Individuals With Recurrent Leishmaniasis, Chronic Leishmaniasis and Asymptomatic Infection
Lead sponsor Yale University, Other
Collaborators National Institute of Allergy and Infectious Diseases (NIAID) NIH
Status Completed
Study type Observational
Conditions Leishmaniasis
Enrollment 438
Start date Dec 1, 2006
Completion Apr 1, 2010
First posted Nov 20, 2006
Last update posted Mar 30, 2020
Countries Colombia

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies